Gene · 7337
NIH grants2,489
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 2,489
Download this page as JSON| Grant | Title | UBE3A papers | Newest fiscal year |
|---|---|---|---|
| R01CA163217 | Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma | 1 | 2025 |
| R01CA163591 | Tumor cell metabolism in action | 1 | 2025 |
| R01CA193343 | Leveraging genetic mapping for personalized targeting of breast cancer microenvironment | 1 | 2025 |
| R01CA201380 | Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation | 1 | 2025 |
| R01CA212608 | Probing RAS-mediated Signaling with Monobody Inhibitors | 1 | 2025 |
| R01CA231509 | Pro-Drug Enolase Inhibitors in Precision Oncology | 1 | 2025 |
| R01CA246130 | Dissecting and Targeting RB1-Mutant Osteosarcoma | 1 | 2025 |
| R01CA258100 | Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer | 1 | 2025 |
| R01CA260666 | Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias | 1 | 2025 |
| R01CA262623 | Systematic Characterization of Small Nucleolar RNAs in Cancer | 1 | 2025 |
| R01CA266470 | High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging. | 1 | 2025 |
| R01CA272771 | The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer | 1 | 2025 |
| R01DA012864 | Mechanisms and Cellular Function of Opioid Receptor Endocytosis | 1 | 2025 |
| R01DA014204 | Regulation of Dopamine Transporter by Trafficking | 1 | 2025 |
| R01DA022727 | Cell-Contact Mediated Mechanisms Assembling Synapses (R01DA022727) | 1 | 2025 |
| R01DE018304 | ART Modulation of Viral Pathogenesis | 1 | 2025 |
| R01DE026727 | SGK1 and the control of periodontal inflammation | 1 | 2025 |
| R01DE028331 | Immune evasion mechanisms by a tumor herpesvirus in the oral cavity | 1 | 2025 |
| R01DK018477 | Enhancer Connectomes in Regulation of Gene Expression | 1 | 2025 |
| R01DK039520 | New Mechanisms and Functions of the Pro/N Degron and Arg/N-Degron Pathways | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/grants?page=11